Evaluating the Brain Disease Model of Addiction
- Available for pre-order. Item will ship after March 7, 2022
This ground-breaking book advances the fundamental debate about the nature of addiction. As well as presenting the case for seeing addiction as a brain disease, it brings together all the most cogent and penetrating critiques of the brain disease model of addiction (BDMA) and the main grounds for being skeptical of BDMA claims.
The idea that addiction is a brain disease dominates thinking and practice worldwide. However, the editors of this book argue that our understanding of addiction is undergoing a revolutionary change, from being considered a brain disease to a disorder of voluntary behavior. The resolution of this controversy will determine the future of scientific progress in understanding addiction, together with necessary advances in treatment, prevention, and societal responses to addictive disorders. This volume brings together the various strands of the contemporary debate about whether or not addiction is best regarded as a brain disease. Contributors offer arguments for and against, and reasons for uncertainty; they also propose novel alternatives to both brain disease and moral models of addiction. In addition to reprints of classic articles from the addiction research literature, each section contains original chapters written by authorities on their chosen topic. The editors have assembled a stellar cast of chapter authors from a wide range of disciplines – neuroscience, philosophy, psychiatry, psychology, cognitive science, sociology, and law – including some of the most brilliant and influential voices in the field of addiction studies today.
The result is a landmark volume in the study of addiction which will be essential reading for advanced students and researchers in addiction as well as professionals such as medical practitioners, psychiatrists, psychologists of all varieties, and social workers.
Table of Contents
List of Contributors
Nick Heather, Matt Field, Antony Moss and Sally Satel
Section I: For the Brain Disease Model of Addiction
- Introduction to Section I
- Addiction is a Brain Disease, and it Matters
- Neurobiologic Advances from the Brain Disease Model of Addiction
- Time to Connect: Bringing Social Context into Addiction Neuroscience
- Drug Addiction: Updating Actions to Habits to Compulsions Ten Years on
- Is Addiction a Brain Disease? The Incentive-Sensitization View
- Addiction is a Brain Disease (But Does it Matter?)
- Introduction to Section II
- Giving the Neurobiology of Addiction No More Than its Due
- The Brain Disease Model of Addiction: Is it Supported by the Evidence and has it Delivered on its Promises?
- Brain Disease Model of Addiction: Why is it so Controversial?
- Brain Disease Model of Addiction: Misplaced Priorities?
- Addiction and the Brain-Disease Fallacy
- Recovery is Possible: Overcoming ‘Addiction’ and its Rescue Hypotheses
- Superpower Rivalry, the American Grand Narrative, and the BDMA
- My Brain Disease Made Me Do It: Bioethical Implications of the Brain Disease Model of Addiction
- Addiction is a Human Problem but Brain Disease Models Divert Attention and Resources Away from Human Level Solutions
- Before "Rock Bottom"? Problem Framing Effects on Stigma and Change Amongst Harmful Drinkers
- Brain Change in Addiction: Disease or Learning? Implications for Science, Policy, and Care
- Brains or Persons? Is it Coherent to Ascribe Psychological Powers to Brains?
- The Persistence of Addiction is Better Explained by Socioeconomic Deprivation Related Factors Powerfully Motivating Goal-Directed Drug Choice Than by Automaticity, Habit or Compulsion Theories Favoured by the Brain Disease Model
- Addiction and Criminal Responsibility: The Law’s Rejection of the Disease Model
- One Cheer for the Brain Disease Interpretation of Addiction
- Introduction to Section III
- In Search of Addiction in the Brains of Laboratory Animals
- Addiction Treatment Providers' Engagements with the Brain Disease Model of Addiction
- Balancing the Ethical and Methodological Pros and Cons of the BDMA.
- The Making of the Epistemic Project of Addiction in the Brain
- Addiction and the Meaning of Disease
- The Pitfalls of Recycling Substance Use Disorder Criteria to Diagnose Behavioral Addictions
- Introduction to Section IV
- Addiction is Socially Engineered Exploitation of Natural Biological Vulnerability
- Toward an Ecological Understanding of Addiction
- Addiction Biases Choice in the Mind, Brain and Behavior System: Beyond the Brain Disease Model
- Multiple Enactments of the Brain Disease Model: Which Model, When, for Whom and at What Cost?
- The Social Perspective and the BDMA’s Entry into the Non-Medical Stronghold in Sweden and Other Nordic Countries
- Beyond the Medical Model: Addiction as a Response to Trauma and Stress
- Psychotherapeutic Strategies to Enhance Motivation and Cognitive Control
- Addiction is Not (Only) in the Brain: Molar Behavioral Economic Models of Etiology and Cessation of Harmful Substance Use
- Understanding Substance Use Disorders Among Veterans: Virtues of the Multitudinous Self Model
- How an Addiction Ontology can Unify Competing Conceptualizations of Addiction
- Looping Processes in the Development of and Desistance from Addictive Behaviours
- Recovery and Identity: A Socially-Focussed Challenge to Brain Disease Models
- Replacing the BDMA: A Paradigm Shift in the Field of Addiction
Matt Field, Antony Moss, Sally Satel and Nick Heather
Alan I. Leshner - Reprinted from: Science, 278, 45-47, 1997
Nora D. Volkow, George F. Koob, and A. Thomas McLellan – Reprinted from New England Journal of Medicine, 374, 363-371, 2016
Markus Heilig, David H. Epstein, Michael A. Nader and Yavin Shaham – Reprinted from Nature Reviews Neuroscience, 17, 592-599, 2016.
Barry J. Everitt and Trevor W. Robbins , B. - Reprinted from Annual Review of Psychology, 67, 23-50, 2016.
Section II: Against the Brain Disease Model of Addiction
Sally Satel, Nick Heather, Antony Moss and Matt Field
Wayne Hall, Adrian Carter & Cynthia Forlini
Wayne Hall, Adrian Carter and Cynthia Forlini – Reprinted from Lancet Psychiatry, 2, 105-110, 2015.
Nora D. Volkow and George Koob - Reprinted from Lancet Psychiatry, 2, 677-679, 2015.
Wayne Hall, Adrian Carter & Cynthia Forlini - Reprinted from Lancet Psychiatry, 2, 867, 2015.
Sally Satel and Scott O. Lilienfeld – Reprinted from Frontiers in Psychiatry, 4, 141, 2014.
Derek Heim and Rebecca L. Monk
Bruce K. Alexander
Stephen J. Morse
Section III: Unsure About the Brain Disease Model of Addiction
Nick Heather, Sally Satel, Matt Field and Antony Moss
Serge H. Ahmed
Anthony Barnett, Michael Savic, Martyn Pickersgill, Kerry O’Brien, Dan I. Lubman and Adrian Carter
Susanne Uusitalo, and Jaakko Kuorikoski
Matilda Hellman and Michael Egerer
Maèva Flayelle, Adriano Schimmenti, Vladan Starcevic and Joël Billieux
Section IV: Alternatives to the Brain Disease Model of Addiction
Antony Moss, Matt Field, Sally Satel and Nick Heather
Don Ross - Reprinted from: Behavioural Brain Research 386 (2020) 112598 Online.
Paul F. M. J. Verschure and Reinout W. Wiers
Helen Keane, David Moore, and Suzanne Fraser
Jessica Storbjörk, Lena Eriksson and Katarina Winter
Samuel F. Acuff, Jalie A. Tucker, Rudy E. Vuchinich, and and James Murphy
Serife Tekin, Alicia A. Swan, Willie J. Hale, and Mary Jo Pugh
Robert Kelly, Janna Hastings, and Robert West
Beth Collinson and David Best
Bruce K. Alexander
Nick Heather, Antony Moss, Matt Field, and Sally Satel
Nick Heather is Emeritus Professor of Alcohol & Other Drug Studies in the Department of Psychology, School of Life Sciences at Northumbria University, UK. A clinical psychologist by training, he is mainly interested in research on treatment and brief interventions for alcohol problems and in theories of addiction.
Matt Field is a Professor of Psychology at the University of Sheffield, UK where he conducts research into the psychological mechanisms that underlie the development, persistence, and recovery from addiction.
Antony C. Moss is Professor of Addictive Behaviour Science in the Centre for Addictive Behaviours Research, London South Bank University, UK. His interests include theories of addiction, public health aspects and prevention of addictive behaviour, and understanding the needs of individuals and groups who have historically been overlooked in research, treatment, and policy.
Sally Satel is an addiction psychiatrist. She treats patients at a methadone clinic in Washington DC, USA and is interested in conceptual frameworks of addiction.